Literature DB >> 7566643

Intrathecal administration of endothelin-1 in the rat: impact on spinal cord blood flow and the blood-spinal cord barrier.

R Westmark1, L J Noble, K Fukuda, N Aihara, A L McKenzie.   

Abstract

The purpose of this study was to examine the integrity of the blood-spinal cord barrier after intrathecal administration of endothelin-1 (ET-1) in the rat spinal cord. A laser Doppler probe was positioned in the exposed subarachnoid space at the T8 vertebral level. In the first experiment, horseradish peroxidase (HRP), a marker of barrier integrity, was given intravenously prior to the intrathecal application of ET-1. Blood flow was then recorded for 3 h, after which the anesthetized animals were euthanized. In the second experiment, animals exposed to endothelin were recovered after confirming a 50% reduction in blood flow. HRP was given 10 min prior to euthanasia at 24 h post infusion. The intensity of staining for HRP was quantified by optical density in fixed sections of spinal cord. There was a significant sustained reduction in spinal cord blood flow and significant barrier breakdown to HRP at both 3 and 24 h after administration of the peptide. Based upon these results we conclude that intrathecal infusion of ET-1 reduces spinal cord blood flow and results in prolonged breakdown of the blood-spinal cord barrier.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7566643     DOI: 10.1016/0304-3940(95)11638-d

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Intraspinal application of endothelin results in focal ischemic injury of spinal gray matter and restricts the differentiation of engrafted neural stem cells.

Authors:  Richard L Benton; John P Woock; Evelyne Gozal; Michal Hetman; Scott R Whittemore
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

2.  Thrombin inhibits NMDA-mediated nociceptive activity in the mouse: possible mediation by endothelin.

Authors:  Ming Fang; Katalin J Kovács; Lauralei L Fisher; Alice A Larson
Journal:  J Physiol       Date:  2003-04-25       Impact factor: 5.182

Review 3.  Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.

Authors:  Hemant Kumar; Alexander E Ropper; Soo-Hong Lee; Inbo Han
Journal:  Mol Neurobiol       Date:  2016-05-18       Impact factor: 5.590

4.  Evidence for proangiogenic cellular and humoral systemic response in patients with acute onset of spinal cord injury.

Authors:  Edyta Paczkowska; Dorota Rogińska; Ewa Pius-Sadowska; Alina Jurewicz; Katarzyna Piecyk; Krzysztof Safranow; Violetta Dziedziejko; Ryszard Grzegrzółka; Andrzej Bohatyrewicz; Bogusław Machaliński
Journal:  J Spinal Cord Med       Date:  2014-06-26       Impact factor: 1.985

5.  VEGF165 therapy exacerbates secondary damage following spinal cord injury.

Authors:  Richard L Benton; Scott R Whittemore
Journal:  Neurochem Res       Date:  2003-11       Impact factor: 3.996

Review 6.  Molecular basis of vascular events following spinal cord injury.

Authors:  Crina Sinescu; Florian Popa; Valentin Titus Grigorean; Gelu Onose; Aurelia Mihaela Sandu; Mihai Popescu; Gheorghe Burnei; Victor Strambu; Constantin Popa
Journal:  J Med Life       Date:  2010 Jul-Sep

7.  Endothelin-1 Immunoreactivity and its Association with Intramedullary Hemorrhage and Myelomalacia in Naturally Occurring Disk Extrusion in Dogs.

Authors:  D Mayer; A Oevermann; T Seuberlich; M Vandevelde; A Casanova-Nakayama; S Selimovic-Hamza; F Forterre; D Henke
Journal:  J Vet Intern Med       Date:  2016-06-29       Impact factor: 3.333

Review 8.  Operation spinal cord regeneration: Patterning information residing in extracellular matrix glycosaminoglycans.

Authors:  Alexander Lu; Alaina Baker-Nigh; Peng Sun
Journal:  Brain Behav       Date:  2020-01-16       Impact factor: 2.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.